Detalhe da pesquisa
1.
Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis.
Clin Endocrinol (Oxf)
; 100(2): 181-191, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050454
2.
[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study.
Eur J Nucl Med Mol Imaging
; 51(8): 2495-2503, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467922
3.
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment.
Eur J Nucl Med Mol Imaging
; 51(3): 805-819, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932560
4.
Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience.
Prostate
; 83(2): 169-178, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259290
5.
Radioiodine versus no radioiodine outcomes in low-risk differentiated thyroid cancers: A propensity-score matched analysis.
Clin Endocrinol (Oxf)
; 99(5): 483-491, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491776
6.
Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study.
Eur J Nucl Med Mol Imaging
; 50(12): 3777-3789, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462775
7.
Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers.
Eur J Nucl Med Mol Imaging
; 51(1): 233-244, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642703
8.
Appropriateness of 14-year cutoff in pediatric differentiated thyroid cancer: Comparison of clinical characteristics and long-term outcomes in 14 years and younger and 15-18 years age groups.
Pediatr Blood Cancer
; 70(10): e30596, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480165
9.
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve metastatic castration-resistant prostate cancer: a randomized, controlled, phase 2 non-inferiority trial.
Eur J Nucl Med Mol Imaging
; 49(5): 1754-1764, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34842950
10.
18F-NaF PET uptake characteristics of coronary artery culprit lesions in a cohort of patients of acute coronary syndrome with ST-elevation myocardial infarction and chronic stable angina: A hybrid fluoride PET/CTCA study.
J Nucl Cardiol
; 29(2): 558-568, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32720061
11.
Diagnostic Accuracy of 68Ga-PSMA PET/CT for Initial Detection in Patients With Suspected Prostate Cancer: A Systematic Review and Meta-Analysis.
AJR Am J Roentgenol
; 216(3): 599-607, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32755196
12.
'Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: A systematic review and meta-analysis'.
Clin Endocrinol (Oxf)
; 91(6): 718-727, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31569282
13.
COVID-19 related multisystem inflammatory syndrome in children (MIS-C): Role of 18F-FDG PET/CT to assess myocardial involvement.
J Nucl Cardiol
; 29(6): 3546-3547, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624189
14.
Effect of Tulsi (Ocimum sanctum Linn.) Supplementation on Metabolic Parameters and Liver Enzymes in Young Overweight and Obese Subjects.
Indian J Clin Biochem
; 32(3): 357-363, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28811698
15.
Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated Review.
PET Clin
; 19(2): 131-145, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38212213
16.
Promising Therapeutic Activity of 177 Lu-PSMA-617 in Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer : A Pilot Experience.
Clin Nucl Med
; 49(2): 131-137, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38049970
17.
Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177 Lu- PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single-center feasibility study.
Nucl Med Commun
; 45(2): 115-120, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982573
18.
Head-to-Head Comparison of SSTR Antagonist [68Ga]Ga-DATA5m-LM4 with SSTR Agonist [68Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study.
Pharmaceuticals (Basel)
; 17(3)2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543061
19.
Safety and Efficacy of 177 Lu-DOTATATE in Children and Young Adult Population : A Single-Center Experience.
Clin Nucl Med
; 49(7): e312-e318, 2024 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769655
20.
Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: Actinium-225-DOTATATE and Combined Therapies.
PET Clin
; 18(2): 215-221, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858746